| bupropion sustained-release / Generic mfg. |
NCT00285584: Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) |
|
|
| Completed | 1 | 41 | US | Bupropion, Brand name of bupropion used in the trial: Wellbutrin SR, Placebo | NYU Langone Health, National Institute on Drug Abuse (NIDA), GlaxoSmithKline | HIV Infections, Depression | 03/04 | 09/04 | | |
NCT00865111: A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions |
|
|
| Completed | 1 | 26 | US | Bupropion 150 mg Extended-Released Tablet, single dose, Bupropion, Wellbutrin SR® 150 mg Sustained-Release Tablet, single dose | Actavis Inc. | Healthy | 04/06 | 04/06 | | |
NCT00133757: Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers |
|
|
| Completed | 1 | 50 | Canada | Bupropion SR | Centre for Addiction and Mental Health, Canadian Institutes of Health Research (CIHR) | Nicotine Dependence, Tobacco Dependence | | 05/06 | | |
NCT00108173: Brain Reaction to Treatment of Nicotine Dependence |
|
|
| Completed | 1 | 104 | US | Zyban | US Department of Veterans Affairs | Nicotine Dependence | 04/07 | 06/11 | | |
NCT00625859: A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects |
|
|
| Completed | 1 | 27 | US | GSK189075, Bupropion, Placebo | GlaxoSmithKline | Diabetes Mellitus, Type 2 | 04/08 | 04/08 | | |
NCT00625131: Nicotine Patch Pretreatment for Smoking Cessation in PTSD |
|
|
| Completed | 1 | 87 | US | Nicotine, Cognitive Behavioral Therapy for Smoking Cessation, CBT, Bupropion Sustained Release (SR), Zyban, Wellbutrin, Placebo patch | US Department of Veterans Affairs | Stress Disorders, Posttraumatic, Tobacco Use Disorder | 03/13 | 03/13 | | |
| Completed | 1 | 16 | Europe | MDMA, Ecstasy, 3,4-Methylenedioxymethamphetamine, Bupropion, Wellbutrin XR, Zyban, Placebo, capsules containing manitol looking identical to MDMA or bupropion | University Hospital, Basel, Switzerland | Healthy, Substance-related Disorders | 05/13 | 09/13 | | |
NCT02369172: Drug-Drug Interaction Study: ASP2151 and Bupropion |
|
|
| Completed | 1 | 24 | Europe | Bupropion, Zyban, ASP2151 | Maruho Europe Limited | Healthy | 04/15 | 04/15 | | |
NCT02582008: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy |
|
|
| Terminated | 1 | 9 | US | Bupropion Hydrochloride, Amfebutamone, BW 323U66, Forfivo XL, Wellbutrin, Zyban, Laboratory Biomarker Analysis, Nicotine Replacement, Nicotine Replacement Therapy, NRT, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Varenicline, Champix, Chantix, CP-526555 | Wake Forest University Health Sciences, National Cancer Institute (NCI) | Current Smoker, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Nasopharyngeal Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma | 10/18 | 09/19 | | |
NCT04526210: Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants |
|
|
| Completed | 1 | 54 | US | ALXN1840, WTX101, Bis-choline tetrathiomolybdate, Tiomolibdate choline, Bupropion Hydrochloride, Wellbutrin SR 150 | Alexion | Wilson Disease | 05/21 | 05/21 | | |
ChiCTR2300072489: A Single-Center, Open, Fixed-Sequence Phase I Clinical Study to Evaluate the Pharmacokinetic Effects of Multiple Doses of Desidustat Tablets on Single Dose of Bupropion Hydrochloride Sustained-Release Tablets in Healthy Subjects |
|
|
| Not yet recruiting | 1 | 16 | | Desidustat tablets 150 mg, D4, D6, D8, D10, administered 4 times, Bupropion hydrochloride sustained-release tablets 150 mg, D1, D10, administered twice | Henan Privince Hospital of Traditional Chinese Medicine; Kangzhe (Hunan) Pharmaceutical Co., Ltd., Sponsor | Renal anemia | | | | |
ChiCTR2300072490: A single-center, open, fixed-sequence phase I clinical study to evaluate the pharmacokinetics of multiple doses of Desidustat Tablets on a single dose of rosuvastatin calcium tablets in healthy subjects |
|
|
| Not yet recruiting | 1 | 24 | | Desidustat tablets 150 mg, D4, D6, D8, D10, administered 4 times, Bupropion hydrochloride sustained-release tablets 150 mg, D1, D10, administered twice | Henan Privince Hospital of Traditional Chinese Medicine; Kangzhe (Hunan) Pharmaceutical Co., Ltd., Sponsor | Renal anemia | | | | |
